OPKO Health to Hold Virtual R&D Day on March 20, 2023

Rhea-AI Summary

OPKO Health, Inc. (NASDAQ: OPK) has announced an R&D Day event scheduled for March 20, 2023, at 4:00 p.m. Eastern time. This two-hour virtual event will feature presentations from OPKO executives regarding ModeX Therapeutics' multispecific technology platforms, focusing on oncology and infectious diseases. Management will also discuss the MDX-2201 technology associated with a recently announced collaboration with Merck for a vaccine targeting Epstein-Barr virus. Attendees can access the live and archived webcast on OPKO’s Investor Relations website and participate in a Q&A session afterward.

Positive

• R&D Day event scheduled for March 20, 2023, to showcase advancements in oncology and infectious diseases.
• Focus on MDX-2201 technology related to the vaccine collaboration with Merck, indicating strategic partnerships.

Negative

• None.

MIAMI, March 09, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that it will hold an R&D Day event on March 20, 2023 beginning at 4:00 p.m. Eastern time. The two-hour virtual event will provide an opportunity to hear from OPKO executives about the ModeX Therapeutics multispecific technology platforms and applications in oncology and infectious diseases. Management will also review the MDX-2201 technology underlying the recently announced license and collaboration agreement with Merck for a vaccine against Epstein-Barr virus. Presenters will include:

• Phillip Frost, M.D., Chief Executive Officer and Chairman
• Elias Zerhouni, M.D., President and Vice Chairman
• Gary Nabel, M.D., Ph.D., Chief Innovation Officer
• Ronnie Wei, Ph.D., Head of Biologics Discovery and Development, ModeX Therapeutics
• John Mascola, M.D., Chief Scientific Officer, ModeX Therapeutics
• Vijay Chhajlani, Ph.D., Chief Technology Officer, ModeX Therapeutics

There is no need to pre-register for the event. A live and archived webcast will be available on OPKO’s Investor Relations website. Following management’s presentations, a Q&A session will be available via the chat function of the webcast.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com

FAQ

What is the date of OPKO's R&D Day event in 2023?

OPKO's R&D Day event is scheduled for March 20, 2023.

What topics will be discussed during OPKO's R&D Day event?

The event will cover ModeX Therapeutics' technology platforms and the MDX-2201 technology related to the Epstein-Barr virus vaccine.

Who will present at OPKO's R&D Day event?

Presenters include Phillip Frost, Elias Zerhouni, Gary Nabel, and other executives.

Will the OPKO R&D Day event be available for later viewing?

Yes, a live and archived webcast will be available on OPKO’s Investor Relations website.

Is pre-registration needed for OPKO's R&D Day event?

No, pre-registration is not required for the event.